A phase II trial of paclitaxel and epirubicin in advanced breast cancer

Initial trials of paclitaxel and doxorubicin in advanced breast cancer yielded high response rates but significant cardiac toxicity was observed. In this phase II trial we investigated the efficacy and safety of paclitaxel combined with epirubicin. Patients with advanced breast cancer, performance s...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Rischin, D, Smith, J, Millward, M, Lewis, C, Boyer, M, Richardson, G, Toner, G, Gurney, H, McKendrick, J
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2000
Gaiak:
Regular Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2374646/
https://ncbi.nlm.nih.gov/pubmed/10945487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1306
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak